Help make medicines safer by reporting suspected side effects

"The Health Products Regulatory Authority (HPRA) is taking part in the third annual social media campaign to promote the importance of reporting suspected side effects from medicines. A number of organisations, including the European Medicines Agency,...
Read More »

Operation Pangea XI 2018

*90,000 illegal medicines worth €376,000 detained in Ireland by the HPRA during Operation Pangea XI* *Globally 10.1 million dosage units of illegal medicines and medical devices with an estimated value of US$14 million detained across all...
Read More »

Are you ready for the implementation of the Falsified Medicines Directive 2011/62/EU?

Falsified Medicines Directive 2011/62/EU
Read More »

HPRA Update - Brexit Guidance for Stakeholders

The following update has been issued by the HPRA. *Brexit Guidance for Stakeholders * *Human and veterinary medicines* *Wednesday, 20th December 2017 *To view this update, please visit the following link: http://www.hpra.ie/docs/default-source/publications-forms/guidance-documents/hpra-brexit-guidance---human-and-veterinary-medicines.pdf?sfvrsn=6[http://www.hpra.ie/docs/default-source/publications-forms/guidance-documents/hpra-brexit-guidance---human-and-veterinary-medicines.pdf?sfvrsn=6]
Read More »

Operation Pangea X

*Global Operation Targeting Falsified Medicines*  25/09/2017 *Over 200,000 illegal medicines worth €850,000 detained in Ireland*.  *Globally 25 million unites seized worth US$56 million* The Health Products Regulatory Authority (HPRA), in partnership with Revenue's Customs Service and An Garda Siochána...
Read More »

HPRA Drug Safety on Valproate (Epilim) and Domperidone

The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines: Valproate (Epilim) and Developmental Disorders: Update on ongoing EU review Domperidone-containing medicines: reminder...
Read More »

HPRA Update

The following update has been issued by the HPRA. *Guide to Reporting and Initial Investigation of Quality Defects in Medicinal* *Products for Human and Veterinary Use* Friday, July 14, 2017 To view this update, please visit the following...
Read More »

Gold Standard for RPs in the UK

Cogent SSC, the employer-led, strategic skills body for the science industries in the UK, has announced a new Gold Standard role profile for Responsible Person in Medicinal Products. The release of the RP Gold Standard follows...
Read More »